Citius Oncology, Inc.
CTOR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $17 | $15 | $14 | $8 |
| Other Curr. Assets | $1 | $3 | $3 | $3 |
| Total Curr. Assets | $18 | $18 | $17 | $11 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $73 | $73 | $73 | $73 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $73 | $73 | $73 | $73 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92 | $91 | $90 | $84 |
| Liabilities | – | – | – | – |
| Payables | $9 | $8 | $6 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $44 | $42 | $38 | $29 |
| Total Curr. Liab. | $53 | $50 | $43 | $33 |
| LT Debt | $4 | $4 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $2 | $2 | $2 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $6 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $4 |
| Total Liabilities | $59 | $56 | $49 | $38 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$59 | -$54 | -$46 | -$39 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $91 | $89 | $87 | $85 |
| Total Equity | $32 | $36 | $41 | $46 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $92 | $91 | $90 | $84 |
| Net Debt | $4 | $4 | $4 | $4 |